Importantly, we found that a fraction of tumor samples in several types of malignancy carry one or more deleted alleles of HTATSF1. For instance, nearly 15% of breast tumor samples from the TCGA datasets have HTATSF1 deletions, and the number of this event is similar in lung tumors (Fig. 1D). This evidence concerns the gene HTATSF1 and neoplasm.